» Articles » PMID: 36973261

Single Cell Analysis in Head and Neck Cancer Reveals Potential Immune Evasion Mechanisms During Early Metastasis

Abstract

Profiling tumors at single-cell resolution provides an opportunity to understand complexities underpinning lymph-node metastases in head and neck squamous-cell carcinoma. Single-cell RNAseq (scRNAseq) analysis of cancer-cell trajectories identifies a subpopulation of pre-metastatic cells, driven by actionable pathways including AXL and AURK. Blocking these two proteins blunts tumor invasion in patient-derived cultures. Furthermore, scRNAseq analyses of tumor-infiltrating CD8 + T-lymphocytes show two distinct trajectories to T-cell dysfunction, corroborated by their clonal architecture based on single-cell T-cell receptor sequencing. By determining key modulators of these trajectories, followed by validation using external datasets and functional experiments, we uncover a role for SOX4 in mediating T-cell exhaustion. Finally, interactome analyses between pre-metastatic tumor cells and CD8 + T-lymphocytes uncover a putative role for the Midkine pathway in immune-modulation and this is confirmed by scRNAseq of tumors from humanized mice. Aside from specific findings, this study demonstrates the importance of tumor heterogeneity analyses in identifying key vulnerabilities during early metastasis.

Citing Articles

Transcriptome combined with single-cell sequencing explored prognostic markers associated with T cell exhaustion characteristics in head and neck squamous carcinoma.

Liu J, Li P, Zhang Y, Zheng L Sci Rep. 2025; 15(1):8209.

PMID: 40065044 PMC: 11893791. DOI: 10.1038/s41598-025-91299-z.


Analyze the Diversity and Function of Immune Cells in the Tumor Microenvironment From the Perspective of Single-Cell RNA Sequencing.

Ma L, Luan Y, Lu L Cancer Med. 2025; 14(5):e70622.

PMID: 40062730 PMC: 11891933. DOI: 10.1002/cam4.70622.


Tailored therapies for triple-negative breast cancer: current landscape and future perceptions.

Khan Y, Rizvi S, Raza A, Khan A, Hussain S, Khan N Naunyn Schmiedebergs Arch Pharmacol. 2025; .

PMID: 40029385 DOI: 10.1007/s00210-025-03896-4.


High-dimensional deconstruction of HNSC reveals clinically distinct cellular states and ecosystems that are associated with prognosis and therapy response.

Xiao L, Shen Z, Pan Z, Qiu Y, Huang D, Liu Y J Transl Med. 2025; 23(1):254.

PMID: 40025504 PMC: 11872339. DOI: 10.1186/s12967-025-06299-4.


Role of the SOX family in cancer immune evasion: Emerging player and promising therapeutic opportunities.

Li J, Xu Y, Han Y, Yang A, Qian M, Wang B Medicine (Baltimore). 2025; 104(5):e41393.

PMID: 39889187 PMC: 11789896. DOI: 10.1097/MD.0000000000041393.


References
1.
Flint T, Janowitz T, Connell C, Roberts E, Denton A, Coll A . Tumor-Induced IL-6 Reprograms Host Metabolism to Suppress Anti-tumor Immunity. Cell Metab. 2016; 24(5):672-684. PMC: 5106372. DOI: 10.1016/j.cmet.2016.10.010. View

2.
Li H, van der Leun A, Yofe I, Lubling Y, Gelbard-Solodkin D, van Akkooi A . Dysfunctional CD8 T Cells Form a Proliferative, Dynamically Regulated Compartment within Human Melanoma. Cell. 2019; 176(4):775-789.e18. PMC: 7253294. DOI: 10.1016/j.cell.2018.11.043. View

3.
Gulati G, Sikandar S, Wesche D, Manjunath A, Bharadwaj A, Berger M . Single-cell transcriptional diversity is a hallmark of developmental potential. Science. 2020; 367(6476):405-411. PMC: 7694873. DOI: 10.1126/science.aax0249. View

4.
Chen Y, LeBleu V, Carstens J, Sugimoto H, Zheng X, Malasi S . Dual reporter genetic mouse models of pancreatic cancer identify an epithelial-to-mesenchymal transition-independent metastasis program. EMBO Mol Med. 2018; 10(10). PMC: 6180301. DOI: 10.15252/emmm.201809085. View

5.
Winkler J, Abisoye-Ogunniyan A, Metcalf K, Werb Z . Concepts of extracellular matrix remodelling in tumour progression and metastasis. Nat Commun. 2020; 11(1):5120. PMC: 7547708. DOI: 10.1038/s41467-020-18794-x. View